SERTM1 inhibitors are a class of chemical compounds designed to specifically inhibit the SERTM1 protein, a lesser-known member of a larger family of proteins involved in cellular processes such as signaling, transport, and regulation of various biological functions. SERTM1 is thought to play a role in membrane transport or signaling pathways within cells, although its exact functions are not fully elucidated. By inhibiting SERTM1, these compounds can interfere with its role in cellular processes, potentially disrupting pathways where SERTM1 is involved. This can affect cellular communication, signal transduction, or other transport-related mechanisms where the protein plays a regulatory or supporting role.
The development of SERTM1 inhibitors involves structural studies of the protein to identify key binding sites or domains that are critical for its function. These inhibitors are often designed to bind specifically to these active or regulatory regions, blocking SERTM1's interaction with its substrates or other cellular components. The goal is to achieve high specificity in inhibiting SERTM1 while avoiding cross-reactivity with other related proteins that may share structural similarities. This requires a detailed understanding of the molecular architecture of SERTM1, often obtained through techniques like molecular modeling, crystallography, or computational docking studies. By inhibiting SERTM1, these compounds provide valuable tools for studying the protein's role in cellular transport and signaling pathways, helping to clarify its broader significance in maintaining cellular homeostasis and regulation of intracellular processes. The development of SERTM1 inhibitors contributes to the larger field of research focused on understanding membrane proteins and their roles in coordinating complex cellular activities.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Inhibits specific tyrosine kinases, affecting cell signaling and growth. | ||||||
Erlotinib Hydrochloride | 183319-69-9 | sc-202154 sc-202154A | 10 mg 25 mg | $75.00 $121.00 | 33 | |
Inhibits the epidermal growth factor receptor (EGFR) kinase, affecting signaling pathways. | ||||||
AEBSF hydrochloride | 30827-99-7 | sc-202041 sc-202041A sc-202041B sc-202041C sc-202041D sc-202041E | 50 mg 100 mg 5 g 10 g 25 g 100 g | $65.00 $122.00 $428.00 $851.00 $1873.00 $4994.00 | 33 | |
A serine protease inhibitor, used in biochemical research. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
A potent inhibitor of protein phosphatases 1 and 2A. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Inhibits L-type calcium channels, affecting calcium-dependent signaling. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Inhibits autophagy and lysosomal degradation, potentially affecting protein turnover related to SERTM1. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor, which could affect gene expression, potentially influencing SERTM1. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor, used in cancer therapy, might affect SERTM1-related pathways. | ||||||